News Abbott Laboratories

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 00:03:03 02/10/2026 +04			5-day change	1st Jan Change
96.69 ^USD	-2.17%		-4.33%	-22.83%

09-30	Abbott Launches Simplescreen Crc Blood Test in the U.S	CI
09-30	Abbott Launches SimpleScreen Blood Test for Colorectal Cancer	MT

All News

Mentions Relevance

09-30	Abbott Launches Simplescreen Crc Blood Test in the U.S	CI
09-30	Abbott Launches SimpleScreen Blood Test for Colorectal Cancer	MT
09-30	Abbott hosts conference call for third-quarter earnings	PR
09-30	Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio	PR
09-25	Abbott Laboratories : Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications	PU
09-23	Abbott and Berry Street team up on personalized nutrition tracking
09-23	Abbott and Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health	CI
09-23	Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health	PR
09-18	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI
09-17	Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026	CI
09-17	Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 16 to Holders of Record on Oct. 15	MT
09-17	Abbott declares 411th consecutive quarterly dividend	PR
09-15	Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation	CI
09-15	First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care	AQ
09-15	Abbott to pay $385M over infant formula contamination probe	AQ
09-14	Abbott agrees to settlement over closure of largest baby formula plant in the US	AQ
09-14	Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations	MT
09-14	Abbott to Pay $385 Million to Resolve Baby Formula Contamination Claims	DJ
09-14	Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says	RE
09-14	Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall	PR
09-08	Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm	DJ
09-08	Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms	CI
09-08	Abbott Laboratories Wins FDA Approval for Dual-Energy AFib Catheter	MT
09-08	The FDA Clears an Abbott Product
09-01	Colorectal Cancer Alliance and Abbott Launch Online Hub Explaining Unexpected Home Delivery Of Colorectal Cancer Screening Kits	CI